Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies.

Axon Neuroscience GmbH, Rennweg, Vienna, Austria.
Journal of Neurochemistry (Impact Factor: 4.24). 02/2009; 108(5):1167-76. DOI: 10.1111/j.1471-4159.2009.05869.x
Source: PubMed

ABSTRACT Human brain encompasses six tau isoforms, containing either three (3R) or four (4R) repeat domains, all of which participate in the pathogenesis of human tauopathies. To investigate the role of tau protein in the disease, transgenic rat models have been created. However, unlike humans, it has been suggested that rat brain expresses only three 4R tau isoforms. Because of the significance of the number of tau isoforms for faithful reproducibility of neurofibrillary pathology in transgenic rat models, we reopened this issue. Surprisingly, our results showed that adult rat brain contains six tau isoforms like humans. Protein expression of 4R tau isoforms was ninefold higher than 3R isoforms. Furthermore, the protein levels of tau isoforms with none, one or two N-terminal inserts were 30%, 35%, and 35% of total tau, respectively. Moreover, amount and ratio of tau isoforms were developmentally regulated. The levels of 4R tau isoforms progressively increased from early postnatal period until adulthood, whereas the expression of 3R tau isoforms reached maximum at P10 and then gradually declined. Our results show that rat brain encompasses full tau proteome similar to humans. These findings support the use of rat as an animal model in human tauopathies research.

Download full-text


Available from: Jozef Hanes, Oct 16, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is charecterized by progressive and irreversible cognitive and memory impairment. The discovery of familial forms of AD (fAD) in association with specific gene mutations facilitated the generation of numerous rodent models. These models in turn proved valuable for the study of molecular mechanisms underlying AD pathogenesis, and facilitated translational research and preclinical drug development. This study aimed to introduce a new rat model of AD simulating some aspects of the sporadic cases of disease.
    Neuroscience 09/2014; 284. DOI:10.1016/j.neuroscience.2014.09.045 · 3.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: One of the canonical problems of group control is to find local rules through which agents construct specified configurations from arbitrary initial positions. In this paper, we introduce and provide several solutions to the 1-d equigrouping problem, a simple but instructive version of the general spatial configuration problem. We show how deterministic solutions are possible on the linear lattice but not the circle, while the reverse is the case for simple probabilistic solutions. We determine a lower bound on the amount and type of information required by any solution, and relate this information to the geometry of the underlying lattice. Finally, we introduce a concept of an interaction kernel, a tool for investigating algorithms in depth. We use the kernel theory to derive several general facts that characterize the group behavior of all deterministic equigrouping solutions, providing a theoretical framework for algorithm design and analysis that may generalize to more complex group control problems.
    Decision and Control, 2004. CDC. 43rd IEEE Conference on; 01/2005
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human tauopathies represent a heterogeneous group of neurodegenerative disorders such as Alzheimer's disease (AD) that are characterized by the presence of intracellular accumulations of abnormal filaments of protein tau. Presently, AD poses an increasing public health concern, because it affects nearly 2% of the population in industrialized countries and the number of patients is expected to increase threefold within the next 50 years. Therefore, the identification of disease modifying pathways that will lead to the development of novel therapeutic approaches targeting downstream molecular events of the tauopathy is of paramount importance. In order to identify factors that may exacerbate or inhibit the disease phenotype a number of genetically modified rodent models reproducing key clinical, histopathological and molecular hallmarks of human tauopathies were developed. Current tau transgenic rodent models express as a transgene either an individual or all six human wild-type tau isoforms, mutant tau linked to FTDP-17, or structurally modified tau species derived from AD. In this review we will provide an up-to-date account of various facets of the tau neurodegenerative cascade with a special emphasis on the evolution of neurofibrillary tangles, neuronal death and neuroinflammation.
    Acta Neuropathologica 03/2009; 118(1):71-86. DOI:10.1007/s00401-009-0499-y · 9.78 Impact Factor